Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo.
about
Bone Marrow Immunity and MyelodysplasiaMultipotent Mesenchymal Stromal Cells: Possible Culprits in Solid Tumors?Patient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technologyMesenchymal stem cell secretome and regenerative therapy after cancerBiodistribution, migration and homing of systemically applied mesenchymal stem/stromal cellsMesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor MicroenvironmentHuman mesenchymal stem cells are resistant to Paclitaxel by adopting a non-proliferative fibroblastic stateHypoxia induced impairment of NK cell cytotoxicity against multiple myeloma can be overcome by IL-2 activation of the NK cells.Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells.Placental mesenchymal stem cells of fetal and maternal origins demonstrate different therapeutic potentials.Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through β-catenin signaling pathwayFluorescence activated enrichment of CD146+ cells during expansion of human bone-marrow derived mesenchymal stromal cells augments proliferation and GAG/DNA content in chondrogenic media.In vitro migratory aberrancies of mesenchymal stem cells derived from multiple myeloma patients only partially modulated by bortezomib.Upregulation of miR-135b is involved in the impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients.Extracellular vesicles derived from renal cancer stem cells induce a pro-tumorigenic phenotype in mesenchymal stromal cells.Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche?IL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production.CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myeloma.Mesenchymal stem cells in tumor development: emerging roles and concepts.Cytotherapies in multiple myeloma: a complementary approach to current treatments?Improved human mesenchymal stem cell isolation.Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma.Role of the Immune Response in Disease Progression and Therapy in Multiple Myeloma.Multiple myeloma and bone marrow mesenchymal stem cells' crosstalk: Effect on translation initiation.Bone marrow micro-environment is a crucial player for myelomagenesis and disease progression.Contribution of microRNA 24-3p and Erk1/2 to interleukin-6-mediated plasma cell survival.Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease.Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies.Role of brain-derived neurotrophic factor in bone marrow angiogenesis in multiple myeloma.CXCL12-mediated murine neural progenitor cell movement requires PI3Kβ activation.[Investigational Study of Mesenchymal Stem Cells on Lung Cancer Cell Proliferation and Invasion].Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?
P2860
Q26739239-DD3089B1-560A-47A4-B75B-45E8487D1E95Q26798274-5CFF535A-9E77-4ADC-B58A-B80D3CFBF49BQ26821929-4E562EB1-99C5-46A8-8473-EA6A6D119651Q27007499-1B20EE22-FD99-4069-AE3B-03BA206B4150Q28069791-A4316B11-2A1A-4F84-A616-8420A0C8FABFQ28073613-4F1AF119-84FD-4902-9776-75B9838C185EQ28547691-74082E9D-6936-4CBA-B5EB-E414DA48ABDFQ31118586-8BCE45BA-9C6A-4200-A919-6C3CBA9BB31AQ33558170-66BD8161-5036-4D86-8B84-B36B5392392DQ33746577-8BC9B708-F400-419F-98A9-F8E2D2B4735BQ34036138-FBB7AA0B-9199-44BF-B5C7-02D361CA75F7Q34333995-C9388CAF-BA5D-49C5-B493-390DE758EFDBQ34501627-ECB67FDC-666D-4900-BA4C-BBDED800397FQ35040318-F4F52753-8BEB-4985-9F84-B42B50749376Q35781475-F64821C6-DC7A-44B5-85B8-A1E802F499F8Q36289608-9B678D7D-9463-4247-BFCF-93BD2166F162Q36557205-D40495F8-1CE8-4AA8-A629-78964F767C8BQ37694678-402E455C-9CA6-4AAB-9D50-4E9615CC9DC3Q38032086-E75B531C-E320-4070-8D19-36C44D39675EQ38108819-BBB8F3C6-9E9E-4C7D-A76F-5B569CBFFD8CQ38210863-8A307CB7-3ABF-4FF4-9DC2-4DAE5595C17BQ38803932-8A750D0C-65F6-4817-9AD9-8A5C2B8F0D51Q38815399-ECFBF733-2EE6-4B94-8BDE-6A736B0D5756Q38972291-A5325D10-5299-4AD4-AD3D-B5819A81E28DQ39093915-4CCA41B8-BFF6-4BCF-99EB-57A697D7E715Q39112089-93E849C6-798E-48DA-9EEE-80549FAEB479Q39136417-4DB705BD-68B1-41B2-A9C4-AEEFF05C2328Q39379196-FD2BFB87-0C98-405F-B4C6-C5CCA381A816Q42158465-35650819-8382-42B8-95C0-CDC46F088AECQ46895359-0C8F40B3-0F5B-4B6B-988F-E712B002AA4BQ47886798-47B92826-5C8D-42A5-9F52-4BF6E7221721Q51054172-45AE8DB6-D1D9-4475-9A67-8F7069A060B5Q53278677-F791AB6E-CDCA-4C41-9636-D662DF5D2F17Q55471455-EB3EC7E8-876E-4BBA-AAC9-35FE52CF1EB2
P2860
Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Bone marrow-derived mesenchyma ...... l growth in vitro and in vivo.
@en
Bone marrow-derived mesenchyma ...... l growth in vitro and in vivo.
@nl
type
label
Bone marrow-derived mesenchyma ...... l growth in vitro and in vivo.
@en
Bone marrow-derived mesenchyma ...... l growth in vitro and in vivo.
@nl
prefLabel
Bone marrow-derived mesenchyma ...... l growth in vitro and in vivo.
@en
Bone marrow-derived mesenchyma ...... l growth in vitro and in vivo.
@nl
P2093
P2860
P356
P1433
P1476
Bone marrow-derived mesenchyma ...... l growth in vitro and in vivo.
@en
P2093
Ann De Becker
Ben Van Camp
Eline Menu
Ivan Van Riet
Karin Vanderkerken
P2860
P304
P356
10.1002/STEM.787
P577
2012-02-01T00:00:00Z